{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"orforglipron","name":"Orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":33,"objects":{"clinicaltrials-gov-nct05869903-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05869903-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct05869903-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05869903-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05869903-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct05869903-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct05869903-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-08-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05869903","sourceIds":["ctg-observation-nct05869903-2026-08-14-650d7c281987"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05869903 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05869903-2026-08-14-650d7c281987"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05869903 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-14, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05869903-2026-08-14-650d7c281987"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05869903-2026-08-14-650d7c281987"]}],"sources":[{"id":"ctg-observation-nct05869903-2026-08-14-650d7c281987","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05869903 · retained source version 2026-08-14:650d7c2819872ef0fea318709542ccc13485fe54f56741e8b8941e98570fefcd","url":"https://clinicaltrials.gov/study/NCT05869903"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ea2558845630236cbf2c4ee0f4d134aed6bddefbe68f6ca34db37c0a07eb5f78","tierARecordSha256":"88bb10413eeaf86de23e7ff557aa715ddb54a68e2b718af696253d7877829c35"},"integrity":{"algorithm":"sha256","contentSha256":"7447a62b4230e35347269f5ab4e2798fff22b29338bb2ebd9947c6d80d2ed73d"}},"clinicaltrials-gov-nct05872620-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05872620-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct05872620-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05872620-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05872620-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct05872620-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct05872620-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-09-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05872620","sourceIds":["ctg-observation-nct05872620-2026-09-04-4f534ed1ca04"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05872620 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05872620-2026-09-04-4f534ed1ca04"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05872620 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05872620-2026-09-04-4f534ed1ca04"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05872620-2026-09-04-4f534ed1ca04"]}],"sources":[{"id":"ctg-observation-nct05872620-2026-09-04-4f534ed1ca04","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05872620 · retained source version 2026-09-04:4f534ed1ca048f1b35f7bc5a2fafe5bac299316d05924bd32fc4302f59758577","url":"https://clinicaltrials.gov/study/NCT05872620"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"3952dc033edc7dc5dc9044fb3ad50f18348f0a4257260cd567b0d1d9e3be7aa1","tierARecordSha256":"50cb9c5a45867df7420392fa5fb3099cb05c289a5f66c328d25fde176240f55d"},"integrity":{"algorithm":"sha256","contentSha256":"9f8c76b67242422f52fb968f4e0cbb5b1752b03772fb7b1bbd22b285d31bd6b9"}},"clinicaltrials-gov-nct05931380-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05931380-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct05931380-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05931380-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05931380-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct05931380-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct05931380-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-20","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05931380","sourceIds":["ctg-observation-nct05931380-2026-07-20-2d642b7a2f34"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05931380 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05931380-2026-07-20-2d642b7a2f34"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05931380 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-20, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05931380-2026-07-20-2d642b7a2f34"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05931380-2026-07-20-2d642b7a2f34"]}],"sources":[{"id":"ctg-observation-nct05931380-2026-07-20-2d642b7a2f34","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05931380 · retained source version 2026-07-20:2d642b7a2f348bc6ed252e14da168735e5727bb87f276b1c325d47deaca0c514","url":"https://clinicaltrials.gov/study/NCT05931380"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ffcabc586618132e0ab673bbea957a819e501b43db6e7c999e2afa0bb6713e81","tierARecordSha256":"d77a47b7c795f64a2fef598ad4db1b9ee89792cae6311750ba0555a203204b9c"},"integrity":{"algorithm":"sha256","contentSha256":"dbcc44382d5be210409e5383ee6de59a5a8846a03f8750037e578e700e842b8c"}},"clinicaltrials-gov-nct05971940-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct05971940-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct05971940-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05971940-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct05971940-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct05971940-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct05971940-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-09-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT05971940","sourceIds":["ctg-observation-nct05971940-2026-09-03-a1388b0f3170"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT05971940 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05971940-2026-09-03-a1388b0f3170"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT05971940 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-03, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct05971940-2026-09-03-a1388b0f3170"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct05971940-2026-09-03-a1388b0f3170"]}],"sources":[{"id":"ctg-observation-nct05971940-2026-09-03-a1388b0f3170","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT05971940 · retained source version 2026-09-03:a1388b0f31700eea781e04cdcf996aabf310b247ed2d71daab20364015c6b9c8","url":"https://clinicaltrials.gov/study/NCT05971940"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d88ba19064b134be04f24257edab2e6c3d378e8742af584cceff5e813417c564","tierARecordSha256":"776e2062d75f954b988d9e4be80f4e16cab34e8600e8866f3540dc2f1fb81354"},"integrity":{"algorithm":"sha256","contentSha256":"87f50b39b7edffeba93bc73e1d60fdc17e1819bda2f96580c81c3617c6d7b960"}},"clinicaltrials-gov-nct06010004-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06010004-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06010004-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06010004-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06010004-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06010004-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06010004-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-06-30","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06010004","sourceIds":["ctg-observation-nct06010004-2026-06-30-1adde0629026"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06010004 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06010004-2026-06-30-1adde0629026"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06010004 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-06-30, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06010004-2026-06-30-1adde0629026"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06010004-2026-06-30-1adde0629026"]}],"sources":[{"id":"ctg-observation-nct06010004-2026-06-30-1adde0629026","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06010004 · retained source version 2026-06-30:1adde0629026d54c0832da7097cd0974eb7947eb663d91af944911e1c9c236f7","url":"https://clinicaltrials.gov/study/NCT06010004"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1d3452b6647cf829b268420ea6ccd1c27e2c8d7d798ecdec401cbc5147a21f12","tierARecordSha256":"8f946ccebe3a71365c9afacc621cf8ce58c1d2e39f646723b198dd911e7bed2b"},"integrity":{"algorithm":"sha256","contentSha256":"c050aeaf298ecd06bc48a277892996ef20a852361dd4f99be616a1bd453bad5d"}},"clinicaltrials-gov-nct06109311-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06109311-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06109311-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06109311-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06109311-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06109311-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06109311-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-10-01","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06109311","sourceIds":["ctg-observation-nct06109311-2026-10-01-134c016d92c6"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06109311 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-01, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06109311-2026-10-01-134c016d92c6"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06109311 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-01, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06109311-2026-10-01-134c016d92c6"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06109311-2026-10-01-134c016d92c6"]}],"sources":[{"id":"ctg-observation-nct06109311-2026-10-01-134c016d92c6","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06109311 · retained source version 2026-10-01:134c016d92c6ae12ebe38c0a6fd09b7e24725abfbf3446e92523334d5eb07dc3","url":"https://clinicaltrials.gov/study/NCT06109311"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"26b001d8abeb71b2cf20416fe1aff1253d296985553e5c48d2be05a24b68bea2","tierARecordSha256":"332065d1ae21b1e901ffbb1519e97b6b3c8cc98b49bdd70d7317442bef450f07"},"integrity":{"algorithm":"sha256","contentSha256":"448c136020eb5c6c9e18ede418fb66e6893c03c3bb6958b21b08e83d0db9b9d6"}},"clinicaltrials-gov-nct06186622-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06186622-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06186622-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06186622-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06186622-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06186622-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06186622-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-05-22","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06186622","sourceIds":["ctg-observation-nct06186622-2026-05-22-e56f797871c1"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06186622 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06186622-2026-05-22-e56f797871c1"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06186622 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06186622-2026-05-22-e56f797871c1"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06186622-2026-05-22-e56f797871c1"]}],"sources":[{"id":"ctg-observation-nct06186622-2026-05-22-e56f797871c1","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06186622 · retained source version 2026-05-22:e56f797871c111d351137fbe9da048795174ce7a27f81e5d771908661a467748","url":"https://clinicaltrials.gov/study/NCT06186622"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c1ee2cb352582cf1306b5bd278bbd1a8efc9f33044b7a377e03c1a589db1cd2d","tierARecordSha256":"673efba62aa3768435b2fc151f2088b4cb607d993bcc2369b09f7d7ca0c1fd08"},"integrity":{"algorithm":"sha256","contentSha256":"44d7a5443c23afef9067963342de41fff98b37760206d04f2feb860be9754e5e"}},"clinicaltrials-gov-nct06192108-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06192108-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06192108-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06192108-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06192108-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06192108-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06192108-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-10-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06192108","sourceIds":["ctg-observation-nct06192108-2026-10-16-66b3e999a0a5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06192108 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06192108-2026-10-16-66b3e999a0a5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06192108 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-16, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06192108-2026-10-16-66b3e999a0a5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06192108-2026-10-16-66b3e999a0a5"]}],"sources":[{"id":"ctg-observation-nct06192108-2026-10-16-66b3e999a0a5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06192108 · retained source version 2026-10-16:66b3e999a0a57bcc847f23fb7b61435f8858580e9e087224081607a3faac42f6","url":"https://clinicaltrials.gov/study/NCT06192108"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"11277b79a72aae98e551c891c3bcc50e9a4f97c0cdef0178b79980d869269531","tierARecordSha256":"9809df0af04bfaa118313e936fd43d2f716aa7be459b39d0fd5dfdffad3f2a84"},"integrity":{"algorithm":"sha256","contentSha256":"8112fec04b16882180ee031aac540050526efb39babee8b200b78e03f6e710ff"}},"clinicaltrials-gov-nct06370728-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06370728-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06370728-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06370728-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06370728-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06370728-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06370728-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06370728","sourceIds":["ctg-observation-nct06370728-2026-07-17-bc71f3e49a37"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06370728 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06370728-2026-07-17-bc71f3e49a37"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06370728 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06370728-2026-07-17-bc71f3e49a37"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06370728-2026-07-17-bc71f3e49a37"]}],"sources":[{"id":"ctg-observation-nct06370728-2026-07-17-bc71f3e49a37","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06370728 · retained source version 2026-07-17:bc71f3e49a379c830921cbcf0809d7c7f89cf9bdd251aa8c81b3e1d8dfdbd14c","url":"https://clinicaltrials.gov/study/NCT06370728"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ff30babc0d45a91960e6b678ca55e46dc4a894dad8d9c0196d4929d8ddca15c0","tierARecordSha256":"eb52a218c3cbe26535c40eeeb6d14419d7f20046bc6938b566229e2d17b00e29"},"integrity":{"algorithm":"sha256","contentSha256":"cd23fb924fed0ee9cd24f51eecf7d3109477d352e056cb09bbdd1d536a7d56aa"}},"clinicaltrials-gov-nct06440980-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06440980-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06440980-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06440980-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06440980-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06440980-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06440980-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06440980","sourceIds":["ctg-observation-nct06440980-2026-07-17-2d4cddaa7467"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06440980 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06440980-2026-07-17-2d4cddaa7467"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06440980 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-17, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06440980-2026-07-17-2d4cddaa7467"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06440980-2026-07-17-2d4cddaa7467"]}],"sources":[{"id":"ctg-observation-nct06440980-2026-07-17-2d4cddaa7467","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06440980 · retained source version 2026-07-17:2d4cddaa74677b00577ee0e53b5e24a13766d8ade8dd973044f004784fd8a9f5","url":"https://clinicaltrials.gov/study/NCT06440980"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"b37ce633c665242a7d2dbb9c221ad0b55dd18eb46a1b736825da393628743c37","tierARecordSha256":"1adf0aa85fd84d069491db027e7cf9f1e0697d545fa36c8a56d37109e84b81b3"},"integrity":{"algorithm":"sha256","contentSha256":"f6d18e0b0609e1cdac232c804575d70247f940975b5e5c0ba34b93866c052f75"}},"clinicaltrials-gov-nct06649045-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06649045-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06649045-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06649045-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06649045-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06649045-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06649045-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-09-14","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06649045","sourceIds":["ctg-observation-nct06649045-2026-09-14-207838ab6d88"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06649045 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-14, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06649045-2026-09-14-207838ab6d88"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06649045 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-09-14, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06649045-2026-09-14-207838ab6d88"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06649045-2026-09-14-207838ab6d88"]}],"sources":[{"id":"ctg-observation-nct06649045-2026-09-14-207838ab6d88","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06649045 · retained source version 2026-09-14:207838ab6d8848719f36836d4d4c7daf4fe6b311f99d213565488ba5217947ff","url":"https://clinicaltrials.gov/study/NCT06649045"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c8f255c1443256b565c1ae26db0c4bb3b8925f5daf763868b3eca0956d34aa71","tierARecordSha256":"55985b1c480f43d122241230f89b2fea5e6c68e0212bda3a9cdbf7a382d6b2c2"},"integrity":{"algorithm":"sha256","contentSha256":"e8a5d69b9cb1309a9867757a7c3591b19da0ceb88855006dd0fddc3b83dcb6cc"}},"clinicaltrials-gov-nct06672549-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06672549-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06672549-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06672549-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06672549-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06672549-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06672549-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06672549","sourceIds":["ctg-observation-nct06672549-2026-11-04-2aaf76a9bade"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06672549 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06672549-2026-11-04-2aaf76a9bade"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06672549 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06672549-2026-11-04-2aaf76a9bade"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06672549-2026-11-04-2aaf76a9bade"]}],"sources":[{"id":"ctg-observation-nct06672549-2026-11-04-2aaf76a9bade","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06672549 · retained source version 2026-11-04:2aaf76a9bade39e441010e60dc89ac5a715bd5b82e903948a66fad44f10698fb","url":"https://clinicaltrials.gov/study/NCT06672549"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0e97936dfe79dbb308aa816ae3d70b5b0a9829e86a8c76ba52b29486c98d4a19","tierARecordSha256":"97c3ef2adfa96f35da4bfd0bf8ea654f0398b1b2b90fdcb72c5400336bb008df"},"integrity":{"algorithm":"sha256","contentSha256":"b149f3de7bb3a27d38b0668c345205b556a41f23199912b9527c4ddbba6d66bc"}},"clinicaltrials-gov-nct06672939-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06672939-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06672939-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06672939-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06672939-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06672939-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06672939-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06672939","sourceIds":["ctg-observation-nct06672939-2026-11-04-9b372fe8721e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06672939 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06672939-2026-11-04-9b372fe8721e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06672939 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06672939-2026-11-04-9b372fe8721e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06672939-2026-11-04-9b372fe8721e"]}],"sources":[{"id":"ctg-observation-nct06672939-2026-11-04-9b372fe8721e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06672939 · retained source version 2026-11-04:9b372fe8721ef4599a20396f52ae2d62f495708dc86a023c9cdf467aa1a4d3a9","url":"https://clinicaltrials.gov/study/NCT06672939"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8c70abcb737affc8cafdc6a7248be9359da23cfb6eec655b4a79fc8d1ad60ddb","tierARecordSha256":"fad2a03f4a40451c27fdee7a4da599554a4a26e9d3f70575e6302f70b4f6a792"},"integrity":{"algorithm":"sha256","contentSha256":"b3080a626e4a423139053cfa8a94bc8cd4c4943d1209bdb366e03a6a4c1daa9b"}},"clinicaltrials-gov-nct06704763-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06704763-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06704763-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06704763-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06704763-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06704763-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06704763-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-05-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06704763","sourceIds":["ctg-observation-nct06704763-2026-05-26-68ef121fd10d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06704763 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-26, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06704763-2026-05-26-68ef121fd10d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06704763 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-05-26, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06704763-2026-05-26-68ef121fd10d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06704763-2026-05-26-68ef121fd10d"]}],"sources":[{"id":"ctg-observation-nct06704763-2026-05-26-68ef121fd10d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06704763 · retained source version 2026-05-26:68ef121fd10d085d538d8530980c4356e11b9d84a3c40c26ce330fc7929bf792","url":"https://clinicaltrials.gov/study/NCT06704763"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9b9823d9416d1581c47c27f425f4498f2e95e89048eb5891b68257d2b1f4375a","tierARecordSha256":"d7c6011088533f12e0c0f3bff5c73bc61f8f31a201ffb1f688dd09dd5bae4074"},"integrity":{"algorithm":"sha256","contentSha256":"cf30139d156d9e3f9789d07cb4ce6fc4b78552384742ebcf75f139383dff6c9c"}},"clinicaltrials-gov-nct06972459-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06972459-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06972459-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06972459-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06972459-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06972459-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06972459-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-29","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06972459","sourceIds":["ctg-observation-nct06972459-2026-07-29-0b5c98f4f7a4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06972459 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06972459-2026-07-29-0b5c98f4f7a4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06972459 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-29, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06972459-2026-07-29-0b5c98f4f7a4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06972459-2026-07-29-0b5c98f4f7a4"]}],"sources":[{"id":"ctg-observation-nct06972459-2026-07-29-0b5c98f4f7a4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06972459 · retained source version 2026-07-29:0b5c98f4f7a4fa5dfc3930850dbce252b8113286a5f5789c6f79e99cd8c394ca","url":"https://clinicaltrials.gov/study/NCT06972459"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d0c7cf5447202b9ae813c625da8953242dd81cc34f36d45e3aa910616e522eef","tierARecordSha256":"6b1f5209c04bfbd10975129e9f28c9969295c556271f084f8af290759be73922"},"integrity":{"algorithm":"sha256","contentSha256":"d0272fd3cffa996706d51a7214304f825383029f2c41dc820cc3050567942f3f"}},"clinicaltrials-gov-nct06993792-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct06993792-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct06993792-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct06993792-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct06993792-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct06993792-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct06993792-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT06993792","sourceIds":["ctg-observation-nct06993792-2026-07-31-41d9194b5e2e"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT06993792 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06993792-2026-07-31-41d9194b5e2e"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT06993792 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-31, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct06993792-2026-07-31-41d9194b5e2e"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct06993792-2026-07-31-41d9194b5e2e"]}],"sources":[{"id":"ctg-observation-nct06993792-2026-07-31-41d9194b5e2e","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT06993792 · retained source version 2026-07-31:41d9194b5e2e67a34bb238dc2c796cf7aeb3afb9318c2c502f034cff6655520a","url":"https://clinicaltrials.gov/study/NCT06993792"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d4ab8a10fcd531c86b41513d01ae12d59b73d66e4cce1cb2d6b4646d107b46a9","tierARecordSha256":"d7d9cf5ece7b096e1b1826408b496b4ed0714e62f070b095f17d203832f6a77d"},"integrity":{"algorithm":"sha256","contentSha256":"9e9608f87a3c837b149a068256ecd9b64790f4fd148d0c5e598b22302dcc5f54"}},"clinicaltrials-gov-nct07153471-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07153471-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07153471-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07153471-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07153471-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07153471-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07153471-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-10-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07153471","sourceIds":["ctg-observation-nct07153471-2026-10-08-73cc3099cfd4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07153471 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07153471-2026-10-08-73cc3099cfd4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07153471 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07153471-2026-10-08-73cc3099cfd4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07153471-2026-10-08-73cc3099cfd4"]}],"sources":[{"id":"ctg-observation-nct07153471-2026-10-08-73cc3099cfd4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07153471 · retained source version 2026-10-08:73cc3099cfd464fcf4384e100f10ce4c88894c7a613b557f77c01302ad93159d","url":"https://clinicaltrials.gov/study/NCT07153471"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"705c5d4b9a34089d50a523b578eb442535b2d8585c917451e4b6536f954199ea","tierARecordSha256":"4afb26c383bf8fab6c179d47c7934313d3fef4e27c3adbb02d2474163c87aebc"},"integrity":{"algorithm":"sha256","contentSha256":"2edfa2430268ff4277c37daae8646da3ffb45d7c678c106122a7e9e71d67498b"}},"clinicaltrials-gov-nct07202884-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07202884-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07202884-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07202884-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07202884-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07202884-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07202884-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07202884","sourceIds":["ctg-observation-nct07202884-2026-11-04-17e85677abc4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07202884 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07202884-2026-11-04-17e85677abc4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07202884 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07202884-2026-11-04-17e85677abc4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07202884-2026-11-04-17e85677abc4"]}],"sources":[{"id":"ctg-observation-nct07202884-2026-11-04-17e85677abc4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07202884 · retained source version 2026-11-04:17e85677abc422d3564998626714b1e33483add7ba467c7c9506ec0f19767e0e","url":"https://clinicaltrials.gov/study/NCT07202884"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7f9f9a26b180ae7d890e9b640cefb7970ca9627719cfd204cbe7d1228aa2805d","tierARecordSha256":"55d6a31a1ee8ad25ff4b0954e08b6141e71f5118db711054914b0f95488db270"},"integrity":{"algorithm":"sha256","contentSha256":"fdf460146909e39aa338594b528d196ac0d582bd15f51de9993b7c1e583e04be"}},"clinicaltrials-gov-nct07223593-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07223593-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07223593-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07223593-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07223593-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07223593-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07223593-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07223593","sourceIds":["ctg-observation-nct07223593-2026-11-04-18f4ded49c3c"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07223593 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07223593-2026-11-04-18f4ded49c3c"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07223593 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07223593-2026-11-04-18f4ded49c3c"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07223593-2026-11-04-18f4ded49c3c"]}],"sources":[{"id":"ctg-observation-nct07223593-2026-11-04-18f4ded49c3c","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07223593 · retained source version 2026-11-04:18f4ded49c3cbd8d0af32401b632a79b00553b77880aa4a82597620e3e918cdc","url":"https://clinicaltrials.gov/study/NCT07223593"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"7076b3aff4048c19611855bfc6a9c613967a15e9e5d2b2294786e87bd73bb224","tierARecordSha256":"56985417e0b6109823dfcf4d8c4499637b6f4e0f76eccd48cbd6e0b37ca9761b"},"integrity":{"algorithm":"sha256","contentSha256":"a3a3e57129f88d2d4ae72169eafddedf356799cb0899acab843520f1a4bfebe6"}},"clinicaltrials-gov-nct07241390-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07241390-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07241390-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07241390-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07241390-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07241390-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07241390-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07241390","sourceIds":["ctg-observation-nct07241390-2026-11-04-7598815e1ab4"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07241390 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07241390-2026-11-04-7598815e1ab4"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07241390 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07241390-2026-11-04-7598815e1ab4"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07241390-2026-11-04-7598815e1ab4"]}],"sources":[{"id":"ctg-observation-nct07241390-2026-11-04-7598815e1ab4","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07241390 · retained source version 2026-11-04:7598815e1ab40597e9bfda0165051eb2d1ccaec035cd8f8aed50b206e3666569","url":"https://clinicaltrials.gov/study/NCT07241390"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fc835af116eb98ff889d1b9f300c8f097e3899d73887e57dabd36ce41b263a11","tierARecordSha256":"2b56365c126e15adfc29b4ec77c584aa1c44ed961d4c8960fd8b830df5eca69a"},"integrity":{"algorithm":"sha256","contentSha256":"39f298f1f1dc5732574b765cac81d3a6cf25608976d67e089801ef4ff8ab29e4"}},"clinicaltrials-gov-nct07613307-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07613307-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07613307-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07613307-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07613307-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07613307-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07613307-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-10-08","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07613307","sourceIds":["ctg-observation-nct07613307-2026-10-08-da074ba3c544"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07613307 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07613307-2026-10-08-da074ba3c544"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07613307 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-08, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07613307-2026-10-08-da074ba3c544"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07613307-2026-10-08-da074ba3c544"]}],"sources":[{"id":"ctg-observation-nct07613307-2026-10-08-da074ba3c544","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07613307 · retained source version 2026-10-08:da074ba3c544b62bbf705c8d6a596933b9cfda279095f95639d486c1b582da69","url":"https://clinicaltrials.gov/study/NCT07613307"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c6700444d1b7c0dd2629298746d132f4ea8cb229de6fcfacd4353523c9d8c060","tierARecordSha256":"be88b35c12b61bee9e10587b3bd0593a1fff969c3281e8e000c9ecbc25ee567b"},"integrity":{"algorithm":"sha256","contentSha256":"de9d9affc04c708102df06842655be38a06e3df0b35d936101afe7a0874b5639"}},"clinicaltrials-gov-nct07729332-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07729332-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07729332-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07729332-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07729332-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07729332-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07729332-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-07-27","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07729332","sourceIds":["ctg-observation-nct07729332-2026-07-27-e9ddfb04faa8"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07729332 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07729332-2026-07-27-e9ddfb04faa8"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07729332 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-07-27, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07729332-2026-07-27-e9ddfb04faa8"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07729332-2026-07-27-e9ddfb04faa8"]}],"sources":[{"id":"ctg-observation-nct07729332-2026-07-27-e9ddfb04faa8","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07729332 · retained source version 2026-07-27:e9ddfb04faa89848ce642232f09d58fa3ba2e688b272537a82eec0dc36eb6f29","url":"https://clinicaltrials.gov/study/NCT07729332"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"07512555d0063deec482e30f30097457cb0edae66d219cac4592f10edc81f893","tierARecordSha256":"be523cd7f51700324337e81d88e0f0b57488353f759f6a2819bcdf8114756159"},"integrity":{"algorithm":"sha256","contentSha256":"20dc0c52ba04bb572cb5a24ac7d41f10dececfee779bd6852a8bf973a859ad6e"}},"clinicaltrials-gov-nct07739537-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07739537-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07739537-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07739537-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07739537-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07739537-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07739537-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-08-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07739537","sourceIds":["ctg-observation-nct07739537-2026-08-31-ef00ba8e4037"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07739537 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07739537-2026-08-31-ef00ba8e4037"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07739537 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-08-31, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07739537-2026-08-31-ef00ba8e4037"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07739537-2026-08-31-ef00ba8e4037"]}],"sources":[{"id":"ctg-observation-nct07739537-2026-08-31-ef00ba8e4037","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07739537 · retained source version 2026-08-31:ef00ba8e40376d8e591b70e48181c6d11bc6ad50d3b36b087a510e683879f2ac","url":"https://clinicaltrials.gov/study/NCT07739537"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"43873102585b09a36ddc39b40155e846bc55e32a49ea1a278dfdc960022053ad","tierARecordSha256":"092a34f3ca315e6d97de8129ff0682d148aca291de9b9be4d77cd6052494d5bb"},"integrity":{"algorithm":"sha256","contentSha256":"af0df9a60fd36daa73de5e48b215065e42475b3b9b8832e6f31433dabf0f0f2e"}},"clinicaltrials-gov-nct07790861-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07790861-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07790861-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07790861-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07790861-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07790861-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07790861-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-10-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07790861","sourceIds":["ctg-observation-nct07790861-2026-10-13-59e712ae7623"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07790861 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07790861-2026-10-13-59e712ae7623"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07790861 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-10-13, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07790861-2026-10-13-59e712ae7623"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07790861-2026-10-13-59e712ae7623"]}],"sources":[{"id":"ctg-observation-nct07790861-2026-10-13-59e712ae7623","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07790861 · retained source version 2026-10-13:59e712ae7623621d03b7d660582b3f34f771aa4e6fb476a03d2a9d1276166e38","url":"https://clinicaltrials.gov/study/NCT07790861"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"086c3644f3fa4949dbb33288c9119e067e03693a8783cf53628906b0608e7a97","tierARecordSha256":"b02428c6238c3c64d606ea55adf3334c2f3356ce5791b89ebc44a7e56f523703"},"integrity":{"algorithm":"sha256","contentSha256":"d06c4e550a21b86fab3ee42885aaa26e8fdf9ed79ab8028815dddd527d4057cb"}},"clinicaltrials-gov-nct07794579-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07794579-orforglipron:v1","objectPathId":"clinicaltrials-gov-nct07794579-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07794579-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#clinicaltrials-gov-nct07794579-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#clinicaltrials-gov-nct07794579-orforglipron-v1"},"story":{"slug":"clinicaltrials-gov-nct07794579-orforglipron","version":1,"domain":"Clinical trials","dateInSource":"2026-11-05","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07794579","sourceIds":["ctg-observation-nct07794579-2026-11-05-fd16413a3c90"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07794579 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07794579-2026-11-05-fd16413a3c90"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07794579 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was orforglipron.","sourceIds":["ctg-observation-nct07794579-2026-11-05-fd16413a3c90"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07794579-2026-11-05-fd16413a3c90"]}],"sources":[{"id":"ctg-observation-nct07794579-2026-11-05-fd16413a3c90","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07794579 · retained source version 2026-11-05:fd16413a3c904ff5aaba36b0313aafa4a3344173f74dc7d4f29aee53a14e5d0e","url":"https://clinicaltrials.gov/study/NCT07794579"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9b9d491e9762eb25f1ebf17f2bbfeb892d9c78bb38e62363d3ab6cdd256a5c3a","tierARecordSha256":"46f146fee9a83797c91c68023cc652cfe422d14d09bdd3a1b35aa6d512bfc103"},"integrity":{"algorithm":"sha256","contentSha256":"385dff3c75537a16f4f8cb9d49a147957b5b293186cb51bad1aea39f6e7914e2"}},"fda-drugs-nda220934-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda220934:v1","objectPathId":"fda-drugs-nda220934-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda220934/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#fda-drugs-nda220934-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#fda-drugs-nda220934-v1"},"story":{"slug":"fda-drugs-nda220934","version":1,"domain":"Regulatory","dateInSource":"2026-04-01","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA220934","sourceIds":["fda-drugs-nda220934-2026-04-01-182b743dabc5"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 220934 with status AP dated 2026-04-01, and names orforglipron calcium among the application record's active ingredients.","sourceIds":["fda-drugs-nda220934-2026-04-01-182b743dabc5"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 220934 with status AP dated 2026-04-01, and names orforglipron calcium among the application record's active ingredients.","sourceIds":["fda-drugs-nda220934-2026-04-01-182b743dabc5"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda220934-2026-04-01-182b743dabc5"]}],"sources":[{"id":"fda-drugs-nda220934-2026-04-01-182b743dabc5","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA220934 · original submission status AP · 2026-04-01 · dataset 2026-11-16","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA220934%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"213525ad27e9a72fb685289312a4df98d388c9b3a6463633561045785ba29ec8","tierARecordSha256":"182b743dabc556076ed4a7a44a5f7742ad86b48258dc312609b98e4e829914ef"},"integrity":{"algorithm":"sha256","contentSha256":"9a8fc9d91246ed08ba6aad028ef2fb9229f18d99a43a4b3d4bc75be8031219f3"}},"pubmed-pmid-38091541-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38091541-orforglipron:v1","objectPathId":"pubmed-pmid-38091541-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38091541-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091541-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-38091541-orforglipron-v1"},"story":{"slug":"pubmed-pmid-38091541-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2025-07-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.","sourceIds":["pubmed-observation-pmid-38091541-2025-07-03-3db59e0d4464"]},{"id":"summary","text":"PubMed lists PMID 38091541 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091541-2025-07-03-3db59e0d4464"]},{"id":"paragraph-1","text":"PubMed lists PMID 38091541 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091541-2025-07-03-3db59e0d4464"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38091541-2025-07-03-3db59e0d4464"]}],"sources":[{"id":"pubmed-observation-pmid-38091541-2025-07-03-3db59e0d4464","name":"PubMed","sourceClass":"A","title":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. · retained source version 1:2025-07-03:current:3db59e0d44641ad8eaa5029f3754395bce7e2654d165ac66f318be75c2f9c38b","url":"https://pubmed.ncbi.nlm.nih.gov/38091541/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"47daf6b161bfcd8d5f23fadd739be3337e19ac05604668c8b6e9ee9a0510f9e3","tierARecordSha256":"68623797a999d81a93327db167068fca06205444d608197e7999467c90390011"},"integrity":{"algorithm":"sha256","contentSha256":"ffb5f3012961c3a99cf75ffff73e20b202ce7b1c4f98acc775d5a60228ed24dc"}},"pubmed-pmid-38091542-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38091542-orforglipron:v1","objectPathId":"pubmed-pmid-38091542-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38091542-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091542-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-38091542-orforglipron-v1"},"story":{"slug":"pubmed-pmid-38091542-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2025-07-03","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.","sourceIds":["pubmed-observation-pmid-38091542-2025-07-03-9bd704fa04e5"]},{"id":"summary","text":"PubMed lists PMID 38091542 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091542-2025-07-03-9bd704fa04e5"]},{"id":"paragraph-1","text":"PubMed lists PMID 38091542 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091542-2025-07-03-9bd704fa04e5"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38091542-2025-07-03-9bd704fa04e5"]}],"sources":[{"id":"pubmed-observation-pmid-38091542-2025-07-03-9bd704fa04e5","name":"PubMed","sourceClass":"A","title":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. · retained source version 1:2025-07-03:current:9bd704fa04e5ac5b7fd5df4152a66fbcfcb6c5d0ba13474f1b8e68ebe1d518a2","url":"https://pubmed.ncbi.nlm.nih.gov/38091542/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"0b606bf9034876bd51bb71dd99667792b9b5506ccc0ab34e4ea444b397e45f73","tierARecordSha256":"f85af03ea14cb957471207ff3a45aaed228aaf7de116131b9f0d5898083d833f"},"integrity":{"algorithm":"sha256","contentSha256":"c2ba6c5b24aa4a103e1b878e96c385439f0b0b873b849bf7a7c9ab0d15108cb4"}},"pubmed-pmid-38091543-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38091543-orforglipron:v1","objectPathId":"pubmed-pmid-38091543-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38091543-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-38091543-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-38091543-orforglipron-v1"},"story":{"slug":"pubmed-pmid-38091543-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2025-07-01","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply.","sourceIds":["pubmed-observation-pmid-38091543-2025-07-01-4a666e4fc135"]},{"id":"summary","text":"PubMed lists PMID 38091543 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091543-2025-07-01-4a666e4fc135"]},{"id":"paragraph-1","text":"PubMed lists PMID 38091543 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2023-12-14 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38091543-2025-07-01-4a666e4fc135"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38091543-2025-07-01-4a666e4fc135"]}],"sources":[{"id":"pubmed-observation-pmid-38091543-2025-07-01-4a666e4fc135","name":"PubMed","sourceClass":"A","title":"GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply. · retained source version 1:2025-07-01:current:4a666e4fc1356751f3aebf7f2a6e59029b863800b0cb2310413d619e7fcab6ae","url":"https://pubmed.ncbi.nlm.nih.gov/38091543/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"f936ccae3957e0e8c87a285c303bab683d54d7442f4ac5e23237518e0578ff32","tierARecordSha256":"9d8ffc3dc63e691c6eb5ebc4f1b266293817ff69251e03b63f9f6a73bb49c519"},"integrity":{"algorithm":"sha256","contentSha256":"93b3ba28e87eb0d55866ebe36275c6f81658e4beea4dc2a267db57518e2be7f2"}},"pubmed-pmid-41994902-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-41994902-orforglipron:v1","objectPathId":"pubmed-pmid-41994902-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-41994902-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-41994902-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-41994902-orforglipron-v1"},"story":{"slug":"pubmed-pmid-41994902-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight.","sourceIds":["pubmed-observation-pmid-41994902-2026-11-09-7e79a17dba97"]},{"id":"summary","text":"PubMed lists PMID 41994902 in Diabetes, obesity & metabolism as Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41994902-2026-11-09-7e79a17dba97"]},{"id":"paragraph-1","text":"PubMed lists PMID 41994902 in Diabetes, obesity & metabolism as Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-41994902-2026-11-09-7e79a17dba97"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-41994902-2026-11-09-7e79a17dba97"]}],"sources":[{"id":"pubmed-observation-pmid-41994902-2026-11-09-7e79a17dba97","name":"PubMed","sourceClass":"A","title":"Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight. · retained source version 1:2026-11-09:current:7e79a17dba975a39311b82eb639465e6b053d44d8b0d0f29b1691d277bcb33aa","url":"https://pubmed.ncbi.nlm.nih.gov/41994902/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2af99333de25e5dba997163e24bb303538b364635310798960e6937d589e407d","tierARecordSha256":"90518a3d7c9518187f925c2e1bba5418b5f2ef8b04840ee48b2b097fcfccc2bb"},"integrity":{"algorithm":"sha256","contentSha256":"53f50b3fd7a329a2259f392335bf5e3f640b89eeacfd982c5ea964f021266597"}},"pubmed-pmid-42138709-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42138709-orforglipron:v1","objectPathId":"pubmed-pmid-42138709-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42138709-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-42138709-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-42138709-orforglipron-v1"},"story":{"slug":"pubmed-pmid-42138709-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2026-07-21","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"Orforglipron Calcium.","sourceIds":["pubmed-observation-pmid-42138709-2026-07-21-7dbfb1366aab"]},{"id":"summary","text":"PubMed lists PMID 42138709 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2026-07-22 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42138709-2026-07-21-7dbfb1366aab"]},{"id":"paragraph-1","text":"PubMed lists PMID 42138709 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2026-07-22 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42138709-2026-07-21-7dbfb1366aab"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42138709-2026-07-21-7dbfb1366aab"]}],"sources":[{"id":"pubmed-observation-pmid-42138709-2026-07-21-7dbfb1366aab","name":"PubMed","sourceClass":"A","title":"Orforglipron Calcium. · retained source version 1:2026-07-21:current:7dbfb1366aab33686ed272e59f14a92445aff8390e2c8d361a41c4bf10b907e3","url":"https://pubmed.ncbi.nlm.nih.gov/42138709/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"74d61b4be8a7eb47fb139a2ae919ea23bbc5d7e2612248ebde3d40a098c82349","tierARecordSha256":"d5b133b807b82a9211a17826e7c139369274959c55b22194bab06f638690198d"},"integrity":{"algorithm":"sha256","contentSha256":"db0775d5648bf204d3d8fc12cb85afa82d073118f372fc4ab0727e6b53095767"}},"pubmed-pmid-42420063-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42420063-orforglipron:v1","objectPathId":"pubmed-pmid-42420063-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42420063-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-42420063-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-42420063-orforglipron-v1"},"story":{"slug":"pubmed-pmid-42420063-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2026-08-06","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"Orforglipron (Foundayo) for adults with obesity.","sourceIds":["pubmed-observation-pmid-42420063-2026-08-06-94a855d423a0"]},{"id":"summary","text":"PubMed lists PMID 42420063 in Trends in pharmacological sciences as Journal Article, with publication-date metadata of 2026-07-08 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42420063-2026-08-06-94a855d423a0"]},{"id":"paragraph-1","text":"PubMed lists PMID 42420063 in Trends in pharmacological sciences as Journal Article, with publication-date metadata of 2026-07-08 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42420063-2026-08-06-94a855d423a0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42420063-2026-08-06-94a855d423a0"]}],"sources":[{"id":"pubmed-observation-pmid-42420063-2026-08-06-94a855d423a0","name":"PubMed","sourceClass":"A","title":"Orforglipron (Foundayo) for adults with obesity. · retained source version 1:2026-08-06:current:94a855d423a083ec87a13766380afdeebe125313cba78f0511d637c82e6ada01","url":"https://pubmed.ncbi.nlm.nih.gov/42420063/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"d6eee95a3b33069c865f13b8743f00a3b69cfc3fd7502b84d43e6388e09005a0","tierARecordSha256":"abb60d73ec49e295b4e1c9591ed662c929eb3e75a7a00203be67586c7dcf169b"},"integrity":{"algorithm":"sha256","contentSha256":"098386e9d817b6c33391a14abbdaf8372aa79e43134b1bbe297ee5b9d749fe21"}},"pubmed-pmid-43002163-orforglipron-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-43002163-orforglipron:v1","objectPathId":"pubmed-pmid-43002163-orforglipron-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-43002163-orforglipron/","json":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.json#pubmed-pmid-43002163-orforglipron-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/orforglipron.md#pubmed-pmid-43002163-orforglipron-v1"},"story":{"slug":"pubmed-pmid-43002163-orforglipron","version":1,"domain":"Literature metadata","dateInSource":"2026-11-09","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["orforglipron"],"peptides":[{"slug":"orforglipron","url":"https://peptidescanner.com/peptides/orforglipron/"}]},"claims":[{"id":"headline","text":"Orforglipron for Obstructive Sleep Apnea: Research Summary.","sourceIds":["pubmed-observation-pmid-43002163-2026-11-09-ba425677421c"]},{"id":"summary","text":"PubMed lists PMID 43002163 in JAMA as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43002163-2026-11-09-ba425677421c"]},{"id":"paragraph-1","text":"PubMed lists PMID 43002163 in JAMA as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-43002163-2026-11-09-ba425677421c"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-43002163-2026-11-09-ba425677421c"]}],"sources":[{"id":"pubmed-observation-pmid-43002163-2026-11-09-ba425677421c","name":"PubMed","sourceClass":"A","title":"Orforglipron for Obstructive Sleep Apnea: Research Summary. · retained source version 1:2026-11-09:current:ba425677421c9e44b371fa974670d5e862809cc59f2d51789704674af9e633de","url":"https://pubmed.ncbi.nlm.nih.gov/43002163/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"2d858d2e173cf731b3648a01b5413ce9f7f9c77038f3487c503933b3e7f75ddc","tierARecordSha256":"1e992883bc256c7d148a212017e751e857f83a250d2a53bebd63288bbb4e77dc"},"integrity":{"algorithm":"sha256","contentSha256":"d0151b1879be88d35857d308d805fd0e6bea31325e869e4444896a9a5a762535"}}}}
